受强制性开放获取政策约束的文章 - Heidi M Ferguson了解详情
可在其他位置公开访问的文章：6 篇
Design, synthesis, and biological evaluation of a robust, biodegradable dendrimer
DG Van Der Poll, HM Kieler-Ferguson, WC Floyd, SJ Guillaudeu, K Jerger, ...
Bioconjugate chemistry 21 (4), 764-773, 2010
强制性开放获取政策： US National Institutes of Health
Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan
K Riviere, HM Kieler-Ferguson, K Jerger, FC Szoka Jr
Journal of controlled release 153 (3), 288-296, 2011
强制性开放获取政策： US National Institutes of Health
Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs
HM Kieler‐Ferguson, JMJ Fréchet, FC Szoka Jr
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 5 (2 …, 2013
强制性开放获取政策： US National Institutes of Health
Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids
HM Kieler-Ferguson, D Chan, J Sockolosky, L Finney, E Maxey, S Vogt, ...
European Journal of Pharmaceutical Sciences 103, 85-93, 2017
强制性开放获取政策： US Department of Energy, US National Institutes of Health
Chemotherapeutic evaluation of a synthetic tubulysin analogue–dendrimer conjugate in c26 tumor bearing mice
WC Floyd III, GK Datta, S Imamura, HM Kieler‐Ferguson, K Jerger, ...
ChemMedChem 6 (1), 49-53, 2011
强制性开放获取政策： US National Institutes of Health
A robust and quantitative method for tracking liposome contents after intravenous administration
AG Kohli, HM Kieler-Ferguson, D Chan, FC Szoka
Journal of Controlled Release 176, 86-93, 2014
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定